BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7793892)

  • 21. Efficacies of fluconazole, caspofungin, and amphotericin B in Candida glabrata-infected p47phox-/- knockout mice.
    Ju JY; Polhamus C; Marr KA; Holland SM; Bennett JE
    Antimicrob Agents Chemother; 2002 May; 46(5):1240-5. PubMed ID: 11959551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Experimental hematogenous candidiasis caused by Candida krusei and Candida albicans: species differences in pathogenicity.
    Anaissie E; Hachem R; K-Tin-U C; Stephens LC; Bodey GP
    Infect Immun; 1993 Apr; 61(4):1268-71. PubMed ID: 8454330
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapies against murine Candida guilliermondii infection, relationship between in vitro antifungal pharmacodynamics and outcome.
    Paredes K; Pastor FJ; Capilla J; Sutton DA; Mayayo E; Fothergill AW; Guarro J
    Rev Iberoam Micol; 2015; 32(1):34-9. PubMed ID: 24594291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluconazole, D0870, and flucytosine treatment of disseminated Candida tropicalis infections in mice.
    Graybill JR; Najvar LK; Holmberg JD; Luther MF
    Antimicrob Agents Chemother; 1995 Apr; 39(4):924-9. PubMed ID: 7785997
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro and in vivo activities of SCH 56592 against Blastomyces dermatitidis.
    Sugar AM; Liu XP
    Antimicrob Agents Chemother; 1996 May; 40(5):1314-6. PubMed ID: 8723494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of SCH-56592 in a temporarily neutropenic murine model of invasive aspergillosis with an itraconazole-susceptible and an itraconazole-resistant isolate of Aspergillus fumigatus.
    Oakley KL; Morrissey G; Denning DW
    Antimicrob Agents Chemother; 1997 Jul; 41(7):1504-7. PubMed ID: 9210674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of SCH 39304, fluconazole, and ketoconazole for treatment of systemic infections in mice.
    Cacciapuoti A; Loebenberg D; Parmegiani R; Antonacci B; Norris C; Moss EL; Menzel F; Yarosh-Tomaine T; Hare RS; Miller GH
    Antimicrob Agents Chemother; 1992 Jan; 36(1):64-7. PubMed ID: 1590702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the kidney fungal burden in experimental disseminated candidiasis by species of the Candida parapsilosis complex treated with fluconazole, amphotericin B and caspofungin in a temporarily neutropenic murine model.
    Szilágyi J; Földi R; Gesztelyi R; Bayegan S; Kardos G; Juhász B; Majoros L
    Chemotherapy; 2012; 58(2):159-64. PubMed ID: 22626860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the efficacy of cilofungin, fluconazole and amphotericin B in the treatment of systemic Candida albicans infection in the neutropenic mouse.
    Bannatyne RM; Cheng PC; Fong IW
    Infection; 1992; 20(3):168-70. PubMed ID: 1644494
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combination therapy with amphotericin B and fluconazole against invasive candidiasis in neutropenic-mouse and infective-endocarditis rabbit models.
    Sanati H; Ramos CF; Bayer AS; Ghannoum MA
    Antimicrob Agents Chemother; 1997 Jun; 41(6):1345-8. PubMed ID: 9174196
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fluconazole (UK-49,858) treatment of candidiasis in normal and diabetic rats.
    Fisher MA; Lee PG; Tarry WF
    Antimicrob Agents Chemother; 1989 Jul; 33(7):1042-5. PubMed ID: 2551214
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.
    Pfaller MA; Messer SA; Gee S; Joly S; Pujol C; Sullivan DJ; Coleman DC; Soll DR
    J Clin Microbiol; 1999 Mar; 37(3):870-2. PubMed ID: 9986880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida.
    Cacciapuoti A; Loebenberg D; Corcoran E; Menzel F; Moss EL; Norris C; Michalski M; Raynor K; Halpern J; Mendrick C; Arnold B; Antonacci B; Parmegiani R; Yarosh-Tomaine T; Miller GH; Hare RS
    Antimicrob Agents Chemother; 2000 Aug; 44(8):2017-22. PubMed ID: 10898669
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interactions between triazoles and amphotericin B against Cryptococcus neoformans.
    Barchiesi F; Schimizzi AM; Caselli F; Novelli A; Fallani S; Giannini D; Arzeni D; Di Cesare S; Di Francesco LF; Fortuna M; Giacometti A; Carle F; Mazzei T; Scalise G
    Antimicrob Agents Chemother; 2000 Sep; 44(9):2435-41. PubMed ID: 10952592
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dosage-dependent antifungal efficacy of V-echinocandin (LY303366) against experimental fluconazole-resistant oropharyngeal and esophageal candidiasis.
    Petraitis V; Petraitiene R; Groll AH; Sein T; Schaufele RL; Lyman CA; Francesconi A; Bacher J; Piscitelli SC; Walsh TJ
    Antimicrob Agents Chemother; 2001 Feb; 45(2):471-9. PubMed ID: 11158743
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro pharmacodynamics and in vivo efficacy of fluconazole, amphotericin B and caspofungin in a murine infection by Candida lusitaniae.
    Sandoval-Denis M; Pastor FJ; Capilla J; Sutton DA; Fothergill AW; Guarro J
    Int J Antimicrob Agents; 2014 Feb; 43(2):161-4. PubMed ID: 24360922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combined antifungal therapy in a murine infection by Candida glabrata.
    Mariné M; Serena C; Pastor FJ; Guarro J
    J Antimicrob Chemother; 2006 Dec; 58(6):1295-8. PubMed ID: 17012301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SCH-39304 in prevention and treatment of disseminated candidiasis in persistently granulocytopenic rabbits.
    Walsh TJ; Lee JW; Lecciones J; Kelly P; Peter J; Thomas V; Bacher J; Pizzo PA
    Antimicrob Agents Chemother; 1990 Aug; 34(8):1560-4. PubMed ID: 2221866
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy of murine invasive candidiasis with fluconazole and amphotericin B.
    Sugar AM; Hitchcock CA; Troke PF; Picard M
    Antimicrob Agents Chemother; 1995 Mar; 39(3):598-601. PubMed ID: 7793858
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
    Gumbo T; Drusano GL; Liu W; Ma L; Deziel MR; Drusano MF; Louie A
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3695-700. PubMed ID: 16954319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.